Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Duxin Sun

Showing results (191-200 of 287) with videos related to

Pageof 29
Sort By:
Pharmaceutical Research|July 15, 2006
Why is it challenging to predict intestinal drug absorption and oral bioavailability in human using rat modelXianhua Cao, Seth T Gibbs, Lanyan Fang, et al.
Clinical Pharmacokinetics|May 13, 2017
Safety and Tolerability of Intravenous Valproic Acid in Healthy Subjects: A Phase I Dose-Escalation TrialPatrick E Georgoff, Vahagn C Nikolian, Tess Bonham, et al.
Neoplasia (New York, N.Y.)|July 9, 2015
Function of Integrin-Linked Kinase in Modulating the Stemness of IL-6-Abundant Breast Cancer Cells by Regulating γ-Secretase-Mediated Notch1 Activation in CaveolaeEn-Chi Hsu, Samuel K Kulp, Han-Li Huang, et al.
Journal of Medicinal Chemistry|August 12, 2024
Discovery of CW-3308 as a Potent, Selective, and Orally Efficacious PROTAC Degrader of BRD9Changwei Wang, Mi Wang, Yu Wang, et al.
ACS Medicinal Chemistry Letters|June 18, 2021
SD-91 as A Potent and Selective STAT3 Degrader Capable of Achieving Complete and Long-Lasting Tumor RegressionHaibin Zhou, Longchuan Bai, Renqi Xu, et al.
The Journal of Nutritional Biochemistry|April 14, 2023
Corrigendum to "A steamed broccoli sprout diet preparation that reduces colitis via the gut microbiota" [J Nutr Biochem 2023;112:109215]Tao Zhang, Johanna Holman, Delaney McKinstry, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 10, 2016
Sequential co-delivery of miR-21 inhibitor followed by burst release doxorubicin using NIR-responsive hollow gold nanoparticle to enhance anticancer efficacyYu Ren, Ruirui Wang, Lizhang Gao, et al.
Bioorganic & Medicinal Chemistry|April 25, 2020
Synthesis and structure-activity relationships of thieno[2,3-d]pyrimidines as atypical protein kinase C inhibitors to control retinal vascular permeability and cytokine-induced edemaXuwen Liu, Michael W Wilson, Kun Liu, et al.
Nature Microbiology|January 24, 2017
The anti-inflammatory drug mesalamine targets bacterial polyphosphate accumulationJan-Ulrik Dahl, Michael J Gray, Daphne Bazopoulou, et al.
Oncotarget|June 11, 2016
Novel cancer stem cell targets during epithelial to mesenchymal transition in PTEN-deficient trastuzumab-resistant breast cancerLichao Sun, Joseph Burnett, Mari Gasparyan, et al.
Pageof 29

Showing results (191-200 of 287) with videos related to

Sort By:
Pageof 29
Pharmaceutical Research|July 15, 2006
Why is it challenging to predict intestinal drug absorption and oral bioavailability in human using rat modelXianhua Cao, Seth T Gibbs, Lanyan Fang, et al.
Clinical Pharmacokinetics|May 13, 2017
Safety and Tolerability of Intravenous Valproic Acid in Healthy Subjects: A Phase I Dose-Escalation TrialPatrick E Georgoff, Vahagn C Nikolian, Tess Bonham, et al.
Neoplasia (New York, N.Y.)|July 9, 2015
Function of Integrin-Linked Kinase in Modulating the Stemness of IL-6-Abundant Breast Cancer Cells by Regulating γ-Secretase-Mediated Notch1 Activation in CaveolaeEn-Chi Hsu, Samuel K Kulp, Han-Li Huang, et al.
Journal of Medicinal Chemistry|August 12, 2024
Discovery of CW-3308 as a Potent, Selective, and Orally Efficacious PROTAC Degrader of BRD9Changwei Wang, Mi Wang, Yu Wang, et al.
ACS Medicinal Chemistry Letters|June 18, 2021
SD-91 as A Potent and Selective STAT3 Degrader Capable of Achieving Complete and Long-Lasting Tumor RegressionHaibin Zhou, Longchuan Bai, Renqi Xu, et al.
The Journal of Nutritional Biochemistry|April 14, 2023
Corrigendum to "A steamed broccoli sprout diet preparation that reduces colitis via the gut microbiota" [J Nutr Biochem 2023;112:109215]Tao Zhang, Johanna Holman, Delaney McKinstry, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 10, 2016
Sequential co-delivery of miR-21 inhibitor followed by burst release doxorubicin using NIR-responsive hollow gold nanoparticle to enhance anticancer efficacyYu Ren, Ruirui Wang, Lizhang Gao, et al.
Bioorganic & Medicinal Chemistry|April 25, 2020
Synthesis and structure-activity relationships of thieno[2,3-d]pyrimidines as atypical protein kinase C inhibitors to control retinal vascular permeability and cytokine-induced edemaXuwen Liu, Michael W Wilson, Kun Liu, et al.
Nature Microbiology|January 24, 2017
The anti-inflammatory drug mesalamine targets bacterial polyphosphate accumulationJan-Ulrik Dahl, Michael J Gray, Daphne Bazopoulou, et al.
Oncotarget|June 11, 2016
Novel cancer stem cell targets during epithelial to mesenchymal transition in PTEN-deficient trastuzumab-resistant breast cancerLichao Sun, Joseph Burnett, Mari Gasparyan, et al.
Pageof 29